Advanced Oncotherapy 股票

Advanced Oncotherapy 负债 2024

Advanced Oncotherapy 负债

49.09 GBP

股票代码

AVO.L

ISIN

GB00BD6SX109

WKN

A2AL9X

在2024年,Advanced Oncotherapy的债务为49.09 GBP,与前一年0 GBP的总债务相比变动了0%

Advanced Oncotherapy Aktienanalyse

Advanced Oncotherapy在做什么?

上的 Advanced Oncotherapy PLC is a therapeutic company in London, specializing in the development of advanced and precise radiation therapy solutions. The company was founded in 2005 and has since developed a revolutionary technology that allows for the treatment of cancer cells with the highest precision and minimal to no damage to surrounding tissues. Advanced Oncotherapy's business model aims to provide innovative technology solutions that benefit patients throughout their cancer treatment. The company's various branches include research and development, production, sales and distribution, and clinical trials. Advanced Oncotherapy focuses on a direct customer-client relationship by offering customers interesting treatment options that are tailored to the patient's needs. The flagship product of Advanced Oncotherapy is the LIGHT radiation therapy system, which is globally unique due to its precision, accuracy, and effectiveness in the treatment of cancer. With this system, oncologists and radiologists are able to perform innovative radiation therapy that promises better treatment outcomes. The LIGHT technology is based on the principles of intensity-modulated radiation therapy (IMRT) and next-generation particle therapy (NGPT). By using proton beams, radiation therapy can be focused directly on a specific region of the body where cancerous tissue is spreading. Advanced Oncotherapy offers a wide range of services in the field of radiation therapy, including proton accelerators (PROTON), PET/CT systems (positron emission tomography/computed tomography), CT scanners (computed tomography), and other tools and devices. This product line has been specifically developed for the precise radiation of tumors and for the diagnosis of cancer and other related diseases. Advanced Oncotherapy's customers are primarily hospitals, medical centers, and health authorities. In recent years, Advanced Oncotherapy has collaborated closely with various partners such as CERN (European Organization for Nuclear Research), the Royal Marsden Hospital, University College London, and other institutions to continuously improve and develop its technology and products. Milestones in the company's history include the granting of CE marking for the LIGHT system and support for clinical trials through research-intensive university hospitals. The future of Advanced Oncotherapy looks promising, with a strong growth forecast for the global radiation therapy market. With an increasing demand for innovative solutions for cancer treatment, the company can look forward to a growing customer base and an increasing number of partnerships and collaborations. Advanced Oncotherapy will continue to focus on continuously optimizing its technology to provide cancer patients with the best treatment options. Advanced Oncotherapy ist eines der beliebtesten Unternehmen auf Eulerpool.com.

负债的详细信息

Advanced Oncotherapy的债务结构理解

Advanced Oncotherapy的总债务是指该公司欠外部各方的累积金融义务。这可能包括短期和长期贷款、债券、贷款和其他金融工具。评估公司的债务对于评估其财务状况,风险概况以及运营和扩展业务的能力至关重要。

年对年对比

通过对Advanced Oncotherapy多年债务结构的分析,可以洞察公司的财务策略和稳定性。债务的减少可能暗示了财务实力和运营效率,而债务的增加可能表明投资增长或潜在的财务挑战。

对投资的影响

投资者会密切关注Advanced Oncotherapy的债务,因为这会影响公司的风险和收益概况。过度的债务可能导致财务压力,而适度并且管理良好的债务可能是增长和扩张的催化剂。这使得债务成为投资评估的重要一环。

债务波动的解读

Advanced Oncotherapy债务水平的变化可能归因为各种运营和策略因素。债务的增加可能旨在资助扩张项目或提高运营能力,而债务的减少可能意味着利润的实现或是一种减小财务风险和杠杆效应的方法。

关于Advanced Oncotherapy股票的常见问题

Advanced Oncotherapy今年的债务有多高?

Advanced Oncotherapy今年的债务水平为49.09 GBP。

Advanced Oncotherapy的债务与去年相比有多高?

Advanced Oncotherapy的债务与去年相比增长了0% 下降了

Advanced Oncotherapy的投资者高额债务会有什么后果?

对于Advanced Oncotherapy的投资者来说,高额债务可能构成风险,因为它会使公司的财务状况变得较弱,可能会影响其履行义务的能力。

Advanced Oncotherapy的投资者低债务会有什么后果?

低债务意味着Advanced Oncotherapy拥有强大的财务地位,并且能够履行其义务,而不会导致其财务负担过重。

Advanced Oncotherapy的债务增加对公司会有什么影响?

Advanced Oncotherapy的债务增加可能会影响公司的财务状况,从而导致其财务负担增加。

Advanced Oncotherapy的债务减少会对公司产生什么影响?

将Advanced Oncotherapy的债务降低可以增强公司的财务状况并提高其履行财务义务的能力。

Advanced Oncotherapy的债务受哪些因素影响?

影响Advanced Oncotherapy负债的一些因素可能包括投资、收购、运营成本和营业收入的发展。

为什么Advanced Oncotherapy的债务对投资者如此重要?

Advanced Oncotherapy的债务对投资者来说很重要,因为它是公司财务稳定性的指标,并且能向投资者提供有关公司如何履行其财务义务的信息。

Advanced Oncotherapy可以采取哪些战略措施来改变债务状况?

为了改变债务状况,Advanced Oncotherapy可以采取包括削减成本、增加收入、出售资产、接受投资或合作伙伴关系等措施。公司必须对其财务状况进行彻底审查,以确定最佳的战略措施来改变其债务状况。

Advanced Oncotherapy支付多少股息?

在过去的12个月中,Advanced Oncotherapy支付了 的股息。这相当于大约的股息收益率。在未来的12个月内,Advanced Oncotherapy预计将支付0 GBP的股息。

Advanced Oncotherapy的股息收益率有多高?

Advanced Oncotherapy当前的股息收益率为。

Advanced Oncotherapy什么时候支付股息?

Advanced Oncotherapy按季度支付股息。这些股息将在月份分发。

Advanced Oncotherapy的股息有多安全?

Advanced Oncotherapy 在过去0年里每年都支付了股息。

Advanced Oncotherapy的股息有多高?

预计未来12个月的股息将达到0 GBP。这相当于0 %的股息收益率。

Advanced Oncotherapy位于哪个行业?

Advanced Oncotherapy 被分配到“健康”板块。

Wann musste ich die Aktien von Advanced Oncotherapy kaufen, um die vorherige Dividende zu erhalten?

要获得Advanced Oncotherapy在支付的0 GBP的最后一笔股息,你必须在的除息日之前持有该股票于你的账户中。

Advanced Oncotherapy最后一次支付股息是什么时候?

上一次股息发放日期为。

Advanced Oncotherapy在2023年的股息是多少?

在2023年,Advanced Oncotherapy 分配了0 GBP作为股息。

Advanced Oncotherapy 的股息是以哪种货币支付的?

Advanced Oncotherapy的股息将以GBP的形式分配。

股票储蓄计划为投资者提供了一种吸引人的方法,可以长期累积财富。主要优势之一是所谓的成本平均效应:通过定期投入固定金额于股票或股票基金,当价格低时自动买入更多份额,价格高时买入较少,这可能随着时间带来更优惠的平均每份成本。此外,股票储蓄计划还允许小额投资者接触到高价股票,因为他们可以用很小的金额参与其中。定期投资也促进了一种纪律投资策略,并有助于避免情绪化的决策,如冲动买卖。除此之外,投资者还能从股票的潜在增值以及可以再投资的股息分红中获益,这增强了复利效应,从而增加了投资资本的增长。

Andere Kennzahlen von Advanced Oncotherapy

我们对Advanced Oncotherapy 营业额股票的股票分析包括重要的财务指标,如收入、利润、市盈率、市销率、息税折旧摊销前利润,以及有关股息的信息。此外,我们还研究了诸如股票、市值、债务、股东权益和Advanced Oncotherapy 营业额的负债等方面。如果您在寻找关于这些主题的更详细信息,我们在子页面上提供了详细的分析: